Magnetic nanoparticle hyperthermia for prostate cancer

International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Manfred JohannsenAndreas Jordan

Abstract

Magnetic nanoparticles are increasingly used for clinical applications such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia. A novel method of interstitial heating of tumours following direct injection of magnetic nanoparticles has been evaluated in humans in recent clinical trials. In prostate cancer this approach has been investigated in two separate phase I studies, employing magnetic nanoparticle thermotherapy alone and in combination with permanent seed brachytherapy. The feasibility and good tolerability was shown in both trials, using the first prototype of an alternating magnetic field applicator. As with any other heating technique, this novel approach requires specific tools for planning, quality control and thermal monitoring, based on appropriate imaging and modelling techniques. In these first clinical trials a newly developed method for planning and non-invasive calculations of the 3-dimensional temperature distribution based on computed tomography was validated. Limiting factors of the new approach at present are patient discomfort at high magnetic field strengths and irregular intratumoural heat distribution. Until these limitations are overcome and thermoablation can safely be appli...Continue Reading

References

Jan 1, 1993·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·A JordanR Felix
Nov 1, 1996·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·A JordanR Felix
Mar 15, 1997·International Journal of Radiation Oncology, Biology, Physics·M S AnscherM W Dewhirst
Jan 9, 1998·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·A JordanR Felix
Apr 17, 2001·International Journal of Radiation Biology·H H Kampinga, E Dikomey
Jul 6, 2002·Critical Reviews in Oncology/hematology·Bert HildebrandtHanno Riess
Jan 1, 1996·International Journal of Radiation Oncology, Biology, Physics·S RyuJ H Kim
Jul 31, 2002·The Lancet Oncology·P WustP M Schlag
Oct 8, 2003·International Journal of Radiation Oncology, Biology, Physics·John A KalapurakalVythialingam Sathiaseelan
Jun 16, 2004·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·E P Armour, G P Raaphorst
Jul 16, 2004·Journal of Endourology·Manfred JohannsenStefan Loening
Jan 22, 2005·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Wolfgang TillyPeter Wust
Nov 10, 2005·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Mark D HurwitzKullervo Hynynen
Nov 24, 2005·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·M JohannsenA Jordan
Nov 30, 2005·Journal of Neuro-oncology·Andreas JordanRoland Felix
Dec 13, 2005·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Paul R Stauffer
Mar 30, 2007·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Peter WustAndreas Jordan
May 25, 2007·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·M JohannsenS A Loening
Aug 19, 2007·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·S MalutaA B Porcaro
Feb 22, 2008·Molecular Diagnosis & Therapy·Keith B HartmanMichael G Rosenblum

❮ Previous
Next ❯

Citations

Jan 5, 2013·Current Opinion in Urology·Jonathan A Coleman, Peter T Scardino
Oct 23, 2009·Journal of the Royal Society, Interface·Eyk Schellenberger
Mar 24, 2012·BMC Neuroscience·Josephine PinkernelleGerburg Keilhoff
Jan 13, 2010·Environmental Health Perspectives·Peter WickUrsula von Mandach
Apr 19, 2011·International Journal of Nanomedicine·Héctor L Rodríguez-LuccioniMadeline Torres-Lugo
Jun 16, 2011·International Journal of Nanomedicine·André C SilvaLionel F Gamarra
Mar 10, 2012·International Journal of Nanomedicine·Ramya RanganathanGanesh Venkatraman
Jul 13, 2011·International Journal of Molecular Sciences·Daisuke KamiMasashi Toyoda
Aug 6, 2013·International Journal of Molecular Sciences·Arati G KolhatkarT Randall Lee
Nov 16, 2013·International Journal of Molecular Sciences·Bashar IssaYousef Haik
Apr 17, 2012·Therapeutic Delivery·Dev Kumar ChatterjeeSunil Krishnan
Jul 24, 2012·Therapeutic Delivery·Roland StoneFrank Alexis
Feb 22, 2014·Actas urologicas españolas·F Gómez-VeigaM Emberton
Mar 22, 2014·Nanomedicine·Dhirender SinghHoward E Gendelman
Apr 29, 2014·Cancer Letters·Xia WuXiaoming Yang
Dec 6, 2014·Journal of Magnetism and Magnetic Materials·Bradley W FickoSolomon G Diamond
Dec 17, 2014·Seminars in Oncology·Mark Hurwitz, Paul Stauffer
Mar 27, 2015·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Anilchandra AttaluriRobert Ivkov
Nov 12, 2015·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Ki Soo Kim, Soo Yeol Lee
Jan 29, 2013·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Boi Hoa SanKyeong Kyu Kim
Jan 30, 2014·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Christopher J RivetDiana-Andra Borca-Tasciuc
Jan 14, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Alexander LeBrunLiang Zhu
Aug 24, 2013·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Silvio Dutz, Rudolf Hergt
Sep 21, 2013·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Tiago R OliveiraMark W Dewhirst
Oct 9, 2013·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Cordula GrüttnerFritz Westphal
Sep 16, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Lisa BregoliAdriele Prina-Mello
Jul 17, 2012·Urologic Oncology·G BozziniN Betrouni
Jun 12, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Michael L EtheridgeJeffrey McCullough
Jul 7, 2011·Advanced Drug Delivery Reviews·Sudeshna ChandraD Bahadur
Jul 9, 2014·ACS Applied Materials & Interfaces·Antonio CervadoroPaolo Decuzzi
Mar 5, 2016·Chemical Reviews·Zahraa Al-Ahmady, Kostas Kostarelos
Nov 9, 2011·Journal of Biomedical Materials Research. Part a·Marie-Christin LamkowskyRalf Dringen
May 24, 2011·Advances in Colloid and Interface Science·Sophie LaurentMorteza Mahmoudi
Oct 9, 2015·Nanoscale Research Letters·Cristian IacovitaConstantin M Lucaciu
Mar 31, 2015·Nanoscale·Bennett E SmithPeter J Pauzauskie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.